2-Brom-3-methylpentan | 62168-41-6

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机溴化物
• 英文名称: 2-Brom-3-methylpentan
• 英文别名: 2-bromo-3-methyl-pentane；2-Bromo-3-methylpentane
• CAS: 62168-41-6
• 化学式: C₆H₁₃Br
• 分子量: 165.073
• InChiKey: XAIYCDIAGUESKG-UHFFFAOYSA-N

物化性质

• 熔点：
  -44.22°C (estimate)
• 沸点：
  147.26°C (estimate)
• 密度：
  1.1700

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  7
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为产物：
  描述：

  1,2,3-三甲基环丙烷 在 氢溴酸 作用下， 生成 2-Brom-3-methylpentan
  参考文献：
  名称：

  Stereochemistry of free radical ring cleavage of cis-1,2,3-trimethylcyclopropane by bromine

  摘要：

  DOI：

  10.1021/ja00784a038

文献信息

• Anti-infective agents
  申请人：——

  公开号：US20040087577A1

  公开（公告）日：2004-05-06

  Compounds having the formula 1 are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.

  具有公式1的化合物是丙型肝炎（HCV）聚合酶抑制剂。还公开了一种用于抑制丙型肝炎（HCV）聚合酶的组成和方法，用于制造这些化合物的过程，以及在这些过程中使用的合成中间体。
• N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl, or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
  申请人：American Cyanamid Company

  公开号：US20020188120A1

  公开（公告）日：2002-12-12

  Matrix metalloproteinases (MMPs) are a group of enzymes that have been implicated in the pathological destruction of connective tissue and basement membranes. These zinc containing endopeptidases consist of several subsets of enzymes including collagenases, stromelysins and gelatinases. TNF-&agr; converting enzyme (TACE), a pro-inflammatory cytokine, catalyzes the formation of TNF-&agr; from membrane bound TNF-&agr; precursor protein. It is expected that small molecule inhibitors of MMPs and TACE therefore have the potential for treating a variety of disease states. The present invention provides low molecular weight, non-peptide inhibitors of matrix metalloproteinases (MMPs) and TNF-&agr; converting enzyme (TACE) for the treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and HIV infection having the formula 1 wherein R 2 and R 3 form a heterocyclic ring and A is S, S(O), or S(O)2, and R 1 and R 4 are defined herein.

  基质金属蛋白酶（MMPs）是一组酶，已被认为与结缔组织和基底膜的病理性破坏有关。这些含锌内切酶包括几个酶亚组，包括胶原酶、基质金属蛋白酶和明胶酶。TNF-α转化酶（TACE）是一种促炎细胞因子，催化膜结合的TNF-α前体蛋白形成TNF-α。因此，MMPs和TACE的小分子抑制剂有潜力用于治疗多种疾病状态。本发明提供了基质金属蛋白酶（MMPs）和TNF-α转化酶（TACE）的低分子量、非肽抑制剂，用于治疗关节炎、肿瘤转移、组织溃疡、异常伤口愈合、牙周病、骨病、糖尿病（胰岛素抵抗）和HIV感染，其化学式为1，其中R2和R3形成杂环环，A为S、S（O）或S（O）2，R1和R4如本文所定义。
• N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
  申请人：American Cyanamid Company

  公开号：US20020032186A1

  公开（公告）日：2002-03-14

  Matrix metalloproteinases (MMPs) are a group of enzymes that have been implicated in the pathological destruction of connective tissue and basement membranes. These zinc containing endopeptidases consist of several subsets of enzymes including collagenases, stromelysins and gelatinases. TNF-&agr; converting enzyme (TACE), a pro-inflmatory cytokine, catalyzes the formation of TNF-&agr; from membrane bound TNF-&agr; precursor protein. It is expected that small molecule inhibitors of MMPs and TACE therefore have the potential for treating a variety of disease states. The present invention provides low molecular weight, non-peptide inhibitors of matrix metalloproteinases (MMPs) and TNF-&agr; converting enzyme (TACE) for the treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and HIV infection having the formula 1 wherein R 2 and R 3 form a heterocyclic ring and A is S, S(O), or S(O) 2 , and R 1 and R 4 are defined herein.

  基质金属蛋白酶（MMPs）是一组酶，已被证明与结缔组织和基底膜的病理性破坏有关。这些含锌内切酶包括几个亚组酶，包括胶原酶、基质金属蛋白酶和明胶酶。TNF-α转化酶（TACE）是一种促炎细胞因子，它催化从膜结合的TNF-α前体蛋白形成TNF-α。因此，MMPs和TACE的小分子抑制剂有治疗多种疾病的潜力。本发明提供了低分子量、非肽类的基质金属蛋白酶（MMPs）和TNF-α转化酶（TACE）抑制剂，用于治疗关节炎、肿瘤转移、组织溃疡、异常愈合、牙周病、骨病、糖尿病（胰岛素抵抗）和HIV感染，其化学式为1，其中R2和R3形成杂环环，A为S、S（O）或S（O）2，R1和R4如本文所定义。
• CYCLOSPORIN DERIVATIVES
  申请人：Fischer Gunter

  公开号：US20140316104A1

  公开（公告）日：2014-10-23

  The present invention relates to novel cyclosporin derivatives that do not cross the cellular membrane. The compounds according to the invention are used in medicine, more particularly in the treatment/diagnosis of acute and chronic inflammatory diseases, viral infections, cancer, degenerative muscle diseases, neurodegenerative diseases and damage that is associated with calcium homeostasis impairment. The novel cyclosporin derivatives additionally have no immunosuppressive effect.

  本发明涉及一种新型环孢霉素衍生物，其不穿过细胞膜。本发明的化合物用于医学，特别是用于治疗/诊断急性和慢性炎症性疾病、病毒感染、癌症、退行性肌肉疾病、神经退行性疾病以及与钙稳态障碍相关的损伤。这些新型环孢霉素衍生物还没有免疫抑制作用。
• Tricyclic compounds having fungicidal activity, their preparation and their use
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0807631A1

  公开（公告）日：1997-11-19

  Compounds of formula (I): [in which: R1 represents halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, cycloalkyl, or cycloalkyloxy; R2 represents hydrogen or halogen; R3 represents hydrogen, alkyl, or cycloalkyl; and the dotted line represents a single or double carbon-carbon bond]; and salts thereof have valuable fungicidal activities which make them of considerable value in agriculture and horticulture.

  式(I)化合物： 其中R1 代表卤素、烷基、卤代烷基、烷氧基、卤代烷氧基、环烷基或环烷氧基；R2 代表氢或卤素；R3 代表氢、烷基或环烷基；虚线代表单碳碳键或双碳碳键]；及其盐类具有重要的杀菌活性，使其在农业和园艺领域具有相当大的价值。